Vedanta​

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Study Details | VE303 for Prevention of Recurrent Clostridioides Difficile Infection | ClinicalTrials.gov

LUMEN

A randomized, double-blind, placebo-controlled study of LMN-201 for prevention of C. difficile infection recurrence (RePreve)

Study Details | LMN-201 for Prevention of C. Difficile Infection Recurrence | ClinicalTrials.gov

​

​

​